NeuroOne to Host First Quarter Fiscal Year 2022 Earnings Call
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) will host a conference call on February 14, 2022, at 4:30 PM Eastern Time to discuss its first-quarter fiscal results for 2022, which ended on December 31, 2021. This call is part of the company’s commitment to improving surgical care for patients with neurological disorders. Interested parties can access the call via toll-free numbers or the provided webcast link.
- Company's focus on minimally invasive solutions may attract investors.
- Upcoming conference call indicates transparency and communication with stakeholders.
- No financial results or metrics disclosed prior to the conference call could lead to uncertainty among investors.
- Being a developmental stage company may pose investment risks.
EDEN PRAIRIE, Minn., Feb. 2, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today it will host a conference call to discuss financial results for its first quarter of fiscal 2022, ended December 31, 2021, on February 14, 2022 at 4:30 PM Eastern Time.
Conference Call Information
Event Date:
February 14, 2022 - 4:30 PM Eastern Time
Participant Numbers:
Toll Free: 888-506-0062
International: 973-528-0011
Participant Access Code: 502618
Event Webcast URL: https://www.webcaster4.com/Webcast/Page/2821/44395
Replay Number: Toll Free: 877-481-4010
International: 919-882-2331
Replay Passcode: 44395
Event Webcast Replay URL: https://www.webcaster4.com/Webcast/Page/2821/44395
About NeuroOne
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. For more information, visit https://www.n1mtc.com.
Forward Looking Statements
This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Except for statements of historical fact, any information contained in this presentation may be a forward–looking statement that reflects the Company's current views about future events and are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. In some cases, you can identify forward–looking statements by the words or phrases "may," "might," "will," "could," "would," "should," "expect," "intend," "plan," "objective," "anticipate," "believe," "estimate," "predict," "project," "potential," "target," "seek," "contemplate," "continue, "focused on," "committed to" and "ongoing," or the negative of these terms, or other comparable terminology intended to identify statements about the future. Although the Company believes that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our expectations of the future, about which we cannot be certain. Our actual future results may be materially different from what we expect due to factors largely outside our control, including risks and uncertainties related to market and other conditions, the impact of general economic, industry or political conditions in the United States or internationally and those described under the heading "Risk Factors" in our filings with the Securities and Exchange Commission. These forward–looking statements speak only as of the date of this press release and the Company undertakes no obligation to revise or update any forward–looking statements for any reason, even if new information becomes available in the future.
View original content to download multimedia:https://www.prnewswire.com/news-releases/neuroone-to-host-first-quarter-fiscal-year-2022-earnings-call-301474049.html
SOURCE NeuroOne Medical Technologies Corporation
FAQ
When will NeuroOne announce its first quarter fiscal 2022 results?
What is the stock symbol for NeuroOne Medical Technologies Corporation?
How can I join the NeuroOne conference call?
What time is NeuroOne's conference call scheduled?
